opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanooma - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
porcilis ery vet injektioneste, suspensio
intervet international b.v. - erysipelothrix rhusiopathiae bacterium, serotype 2, inactivated - injektioneste, suspensio - erysipelothrix rokote
porcilis ery + parvo vet. injektioneste, suspensio
intervet international b.v. - porcine parvovirus inactivated, strain 014, erysipelothrix rhusiopathiae, inactivated, strain m2, serotype 2 - injektioneste, suspensio - inaktivoitu sian parvovirus -rokote + inaktivoitu erysipelothrix rokote
questran 4 g jauhe oraalisuspensiota varten
cheplapharm arzneimittel gmbh - colestyramine - jauhe oraalisuspensiota varten - 4 g - kolestyramiini
adrenalin 0.1 mg/ml injektioneste, liuos
takeda oy - adrenaline tartrate - injektioneste, liuos - 0.1 mg/ml - adrenaliini
akineton 2 mg tabletti
laboratorio farmaceutico s.i.t s.r.l. - biperiden hydrochloride - tabletti - 2 mg - biperideeni
bemetson 0.1 % emulsiovoide
orion corporation - betamethasone valerate - emulsiovoide - 0.1 % - beetametasoni
bemetson 0.1 % voide
orion corporation - betamethasone valerate - voide - 0.1 % - beetametasoni
bemetson 1 mg/ml liuos päänahkaan
orion corporation - betamethasone valerate - liuos päänahkaan - 1 mg/ml - beetametasoni